Recombinant Human LASS2 Protein，His

LASS2 (Lipid Agnostic Sphingolipid Synthase 2), a member of the LASS family, plays a crucial role in the biosynthesis of sphingolipids, which are vital components of cell membranes and are involved in various cellular processes, including signaling, apoptosis, and cell differentiation. Research into LASS2 has gained attention due to its implications in various diseases, particularly cancer, where it has been linked to tumor progression and metastasis. The enzyme is responsible for synthesizing ceramide, a key sphingolipid that acts as a second messenger in cell signaling pathways. Alterations in LASS2 expression and activity have been associated with pathological conditions, highlighting its potential as a therapeutic target. Understanding the structural and functional properties of LASS2 is essential for developing targeted therapies that could modulate its activity. Consequently, the recombinant expression of LASS2 protein has become a significant focus in biochemical and pharmacological research, providing insights into its enzymatic mechanisms and interactions with other cellular components. This knowledge not only enhances our understanding of sphingolipid metabolism but also paves the way for innovative strategies in treating diseases linked to aberrant sphingolipid signaling. Researchers are employing various expression systems to produce LASS2 for biochemical characterization and functional assays, aiming to elucidate its role in health and disease. Overall, the study of LASS2 as a recombinant protein is pivotal in advancing our understanding of sphingolipid biology and its clinical implications.